Non-alcoholic fatty liver disease.: From insulin resistance to mitochondrial dysfunction

被引:1
|
作者
Herruzo, J. A. Solis
Ruiz, I. Garcia
Carreras, M. Perez
Yague, M. T. Munoz
机构
[1] Univ Complutense Madrid, Hosp 12 Octubre, Ctr Invest,Dept Gastroenterol, Serv Med Aparato Digest,Ctra Andalucia,Res Ctr, Madrid 28041, Spain
[2] Univ Complutense Madrid, Hosp 12 Octubre, Res Ctr, Dept Hepatol, Madrid 28041, Spain
关键词
non-alcoholic fatty liver disease; insulin resistance; mitochondrial dysfunction;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease represents a set of liver lesions similar to those induced by alcohol that develop in individuals with no alcohol abuse. When lesions consist of fatty and hydropic degeneration, inflammation, and eventually fibrosis, the condition is designated non-alcoholic steatohepatitis (NASH). The pathogenesis of these lesions is not clearly understood, but they are associated with insulin resistance in most cases. As a result, abdominal fat tissue lipolysis and excessive fatty acid uptake by the liver occur. This, together with a disturbance of triglyceride export as VLDL, results in fatty liver development. Both the inflammatory and hepatocellular degenerative components of NASH are attributed to oxidative stress. Mitochondrial respiratory chain loss of activity plays a critical role in the genesis of latter stress. This may be initiated by an increase in the hepatic TNF alpha, iNOS induction, peroxynitrite formation, tyrosine nitration and inactivation of enzymes making up this chain. Consequences of oxidative stress include: lipid peroxidation in cell membranes, stellate cell activation in the liver, liver fibrosis, chronic inflammation, and apoptosis.
引用
收藏
页码:844 / 863
页数:20
相关论文
共 50 条
  • [21] Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease
    Videla, Luis A.
    Rodrigo, Ramon
    Araya, Julia
    Poniachik, Jaime
    TRENDS IN MOLECULAR MEDICINE, 2006, 12 (12) : 555 - 558
  • [22] NON-ALCOHOLIC FATTY LIVER DISEASE AND INSULIN RESISTANCE IN FAMILIAL COMBINED HYPERLIPIDEMIA
    Jackuliakova, D.
    Vaverkova, H.
    Karasek, D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 122 - 122
  • [23] Epigenetics and mitochondrial dysfunction insights into the impact of the progression of non-alcoholic fatty liver disease
    Guha, Shreyoshi
    Sesili, Selvam
    Mir, Ishfaq Hassan
    Thirunavukkarasu, Chinnasamy
    CELL BIOCHEMISTRY AND FUNCTION, 2023, 41 (01) : 4 - 19
  • [24] Mitochondrial dysfunction and oxidant production in an animal model of non-alcoholic fatty liver disease
    Mantena, Sudheer K.
    Vaughn, Denly Paul, Jr.
    King, Adrienne L.
    Barnes, Justin
    Abrams, Gary a.
    Bailey, Shannon M.
    FREE RADICAL BIOLOGY AND MEDICINE, 2006, 41 : S148 - S149
  • [25] Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD)
    Ajaz, Saima
    McPhail, Mark J.
    Gnudi, Luigi
    Trovato, Francesca M.
    Mujib, Salma
    Napoli, Salvatore
    Carey, Ivana
    Agarwal, Kosh
    MITOCHONDRION, 2021, 57 : 119 - 130
  • [26] CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE COMPARED TO ALCOHOLIC LIVER DISEASE.
    Abe, Temidayo
    Ajose, Taiwo A.
    Ajose, Afolarin
    Abe, Tolulope
    Patel, Parth
    Sobukonla, Timothy
    Surapaneni, Phani Keerthi
    GASTROENTEROLOGY, 2020, 158 (06) : S346 - S347
  • [27] Non-alcoholic fatty liver disease. How and who to screen
    Teran Lantaron, Alvaro
    Crespo Garcia, Javier
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2011, 34 (04): : 278 - 288
  • [28] Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Bahitham, Wesam
    Alghamdi, Siraj
    Omer, Ibrahim
    Alsudais, Ali
    Hakeem, Ilana
    Alghamdi, Arwa
    Abualnaja, Reema
    Sanai, Faisal M.
    Rosado, Alexandre S.
    Sergi, Consolato M.
    BIOMEDICINES, 2024, 12 (03)
  • [29] Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model
    Rector, R. Scott
    Thyfault, John P.
    Uptergrove, Grace M.
    Morris, E. Matthew
    Naples, Scott P.
    Borengasser, Sarah J.
    Mikus, Catherine R.
    Laye, Matthew J.
    Laughlin, M. Harold
    Booth, Frank W.
    Ibdah, Jamal A.
    JOURNAL OF HEPATOLOGY, 2010, 52 (05) : 727 - 736
  • [30] Clinical Predictors of Recurrent Non-Alcoholic Steatohepatitis Following Liver Transplantation for Non-Alcoholic Fatty Liver Disease.
    Stein, L.
    Dunn, W.
    Nguyen, H.
    Bhasin, D.
    Pollinger, H.
    Johnson, M.
    Shrestha, R.
    TRANSPLANTATION, 2014, 98 : 703 - 703